The Globus Pallidus Internal Segment (GPi), also known as the internal globus pallidus or entopeduncular nucleus in rodents, serves as the primary output nucleus of the basal ganglia motor loop[1]. GPi GABAergic projection neurons provide the main inhibitory signal from the basal ganglia to the thalamus and brainstem, ultimately influencing cortical motor areas and controlling movement execution[2].
GPi neurons are tonically active GABAergic neurons that fire at relatively high rates (~60-80 Hz) in the healthy state, providing continuous inhibition of thalamic motor nuclei[3]. Changes in GPi activity are central to the pathophysiology of Parkinson's disease, Huntington's disease, and other movement disorders, making it a critical target for surgical interventions including pallidotomy and deep brain stimulation[4].
The GPi is located in the basal ganglia, medial to the external globus pallidus (GPe) and lateral to the internal capsule[5]:
| Property | Value |
|---|---|
| Location | Dorsomedial to putamen, lateral to internal capsule |
| Human Coordinates | Approximately A-P: -4 to -8 mm from anterior commissure |
| Cell Types | GABAergic projection neurons (~160,000 in human) |
| Primary Neurotransmitter | GABA |
| Key Markers | GAD65/67, Parvalbumin (PV), Calbindin, LRRK2 |
GPi receives input from several key structures[6]:
Striatum (Direct Pathway)
Subthalamic Nucleus (STN)
External Globus Pallidus (GPe)
Striatum (Indirect Pathway)
Major GPi projections include[7]:
GPi serves as the basal ganglia output station[8]:
| Function | Mechanism |
|---|---|
| Movement Initiation | Disinhibition of thalamic motor circuits |
| Movement Suppression | Prevents unwanted movements |
| Motor Sequencing | Temporal patterning of movements |
| Force Scaling | Modulates movement vigor |
GPi activity is dramatically altered in basal ganglia disorders:
Parkinson's Disease: Increased firing rate, irregular patterns
Huntington's Disease: Decreased activity, altered burst firing
Dystonia: Variable changes depending on type
GPi is central to PD pathophysiology[9]:
Therapeutic Implications:
GPi degeneration in HD[10]:
GPi dysfunction in dystonia[11]:
GPi involvement in PSP[12]:
GPi pathology in CBS[13]:
GPi is a key target for neurosurgical intervention[14]:
| Intervention | Mechanism | Indication |
|---|---|---|
| Pallidotomy | Lesion GPi to reduce output | PD, dystonia |
| GPi-DBS | Electrical modulation of GPi | PD, dystonia, HD |
| Lesioning | Chemical/surgical ablation | Medication-resistant cases |
GPi-DBS uses specific parameters[15]:
Albin JE, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. 1989. ↩︎
Parent A, Hazrati LN. Functional anatomy of the basal ganglia. 1995. ↩︎
Nambu A. A new dynamic model of the cortico-basal ganglia loop. 2004. ↩︎
Vitek JL, Bakay RA, DeLong MR. Microelectrode-guided pallidotomy for treatment of Parkinson's disease. 1997. ↩︎
Yelnik J, Percheron G. Postmortem analysis of the human globus pallidus. 1992. ↩︎
Kita H. Network properties of the basal ganglia. 2007. ↩︎
Smith Y, Bevan MD, Shink E, Bolam JP. Microcircuitry of the direct and indirect pathways of the basal ganglia. 1998. ↩︎
Mink JW. The basal ganglia and involuntary movements. 2003. ↩︎
Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. 1990. ↩︎
Reiner A, Deng YP. The basal ganglia and Huntington's disease. 2018. ↩︎
Vitek JL, Chockkan V, Zhang JY, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia. 1999. ↩︎
Litvan I, Agid Y, Calne D, et al. Clinical research criteria for progressive supranuclear palsy. 1996. ↩︎
Rinne JO, Brooks DJ, Rossor MN, et al. Corticobasal degeneration: a clinical and PET study. 1999. ↩︎
Gross RE. What happened to the pallidotomy for Parkinson's disease? J Neurol Neurosurg Psychiatry. 2015. ↩︎
Vitek JL. Deep brain stimulation for dystonia. 2008. ↩︎